GGrantIndex
Sort

146,196 grants matching diabetes

Molecular interception and immunological characterization of age-associated disease

$746,596
Mark M Davis · Stanford University · P01 · FY2023 · AI

Development of An Automated High-Throughput Dried Blood Spot Assay to Facilitate Large Scale Screening for Type 1 Diabetes Risk

$746,584
David Seftel · Enable Biosciences, Inc. · R44 · FY2019 · DK

Genetic Epidemiology of Cancer

$746,567
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2016 · HG

One-compound, one-islet: A high-throughput platform for small-molecule discovery

$746,566
Bridget K Wagner · Broad Institute, Inc. · U01 · FY2022 · DK

Imaging the Vascular Consequences of Lipid Deposition

$746,491
James Athur Hamilton · Boston University Medical Campus · P50 · FY2009 · HL

CV Benefits and Safety of Glucose-Lowering Therapies in Adults with Diabetes

$746,462
Patrick J O'Connor · Healthpartners Institute · R01 · FY2015 · HL

Individualized Risk Stratification Using the Genomic Contribution

$746,447
Gary Wayne Beecham · University Of Miami School Of Medicine · R01 · FY2011 · HL

Cellular And Molecular Pathogenesis Of Alzheimer

$746,422
Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG

Synaptic Plasticity In Aging And Neurodegenerative Disorders

$746,422
Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG

Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling

$746,370
Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE

Clinical Trial of the Fit Families Multicomponent Obesity Intervetnion for African American Adolescents and Their Caregivers: Next Step from the ORBIT Initiative

$746,364
Phillippe Belton Cunningham · Medical University Of South Carolina · R33 · FY2022 · HL

Gene discoveries in subjects with Crohn's disease of African descent

$746,346
Subra Kugathasan · Emory University · R01 · FY2023 · DK

Enabling electron-induced fragmentation in tandem mass spectrometry

$746,325
Valery G. Voinov · E-Msion, Inc. · R44 · FY2019 · GM

Practical Mass Spectrometer Upgrade for Identifying Fragile Protein Modifications by ECD

$746,325
Valery G. Voinov · E-Msion, Inc. · R44 · FY2017 · GM

Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics

$746,325
Valery G. Voinov · E-Msion, Inc. · R44 · FY2021 · GM

Enabling electron-induced fragmentation in tandem mass spectrometry

$746,325
Valery G. Voinov · E-Msion, Inc. · R44 · FY2018 · GM

Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics

$746,325
Valery G. Voinov · E-Msion, Inc. · R44 · FY2020 · GM

An intravascular Bioartificial Pancreas (iBAP)

$746,324
Charles Blaha · Silicon Kidney, Llc · R44 · FY2018 · DK

Inclusion of Under-Represented Groups Core

$746,287
Carey E Gleason · University Of Wisconsin-Madison · P30 · FY2021 · AG

GENOMIC SCAN FOR ATHEROSCLEROSIS PATHWAY GENES IN AFRICAN-AMERICANS FROM FHS-SCAN

$746,239
Michael A Province · Washington University · R01 · FY2009 · HL

An intravascular Bioartificial Pancreas (iBAP)

$746,229
Charles Blaha · Silicon Kidney, Llc · R44 · FY2019 · DK

Epigenetic roles in regulation of cholesterol metabolism and CVD risk

$746,222
Yongmei Liu · Wake Forest University Health Sciences · R01 · FY2017 · HL

Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists

$746,208
Konrad Talbot · Loma Linda University · R01 · FY2019 · AG

Health Literacy and Cognitive Function among Middle-Aged Adults: The MidCog Study

$746,203
Michael S Wolf · Northwestern University At Chicago · R01 · FY2023 · AG

PFAS Exposure and Diabetic Kidney Disease in Youth with Type 2 Diabetes: A Multi-Omic Approach for Prevention and Treatment

$746,198
Jesse Allen Goodrich · University Of Southern California · R01 · FY2024 · DK